China Investment Corporation (CIC) has teamed up with France-based GP Eurazeo and BNP Paribas to launch a Europe-China growth fund with a target corpus of EUR1-1.5 billion ($1.1-1.7 billion).
According to a release, all three partners will invest significantly in the fund and pursue additional LP commitments. Eurazeo, which has a team of eight professionals in China, will act as fund manager,...
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.